Alcon Inc. (ALC)
NYSE: ALC · Real-Time Price · USD
94.79
-0.96 (-1.00%)
At close: May 12, 2025, 4:00 PM
96.61
+1.82 (1.92%)
After-hours: May 12, 2025, 7:49 PM EDT
Alcon Employees
Alcon had 25,599 employees as of December 31, 2024. The number of employees increased by 284 or 1.12% compared to the previous year.
Employees
25,599
Change (1Y)
284
Growth (1Y)
1.12%
Revenue / Employee
$387,164
Profits / Employee
$39,767
Market Cap
47.02B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 25,599 | 284 | 1.12% |
Dec 31, 2023 | 25,315 | 137 | 0.54% |
Dec 31, 2022 | 25,178 | 789 | 3.24% |
Dec 31, 2021 | 24,389 | 734 | 3.10% |
Dec 31, 2020 | 23,655 | 1,513 | 6.83% |
Dec 31, 2019 | 22,142 | 1,761 | 8.64% |
Dec 31, 2018 | 20,381 | 1,251 | 6.54% |
Dec 31, 2017 | 19,130 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALC News
- 6 days ago - Alcon Announces Results of 2025 Annual General Meeting - Business Wire
- 17 days ago - Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS - Business Wire
- 5 weeks ago - Alcon Publishes Agenda for 2025 Annual General Meeting - Business Wire
- 5 weeks ago - Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter - Business Wire
- 6 weeks ago - Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease - Business Wire
- 6 weeks ago - LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR - Business Wire
- 6 weeks ago - Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities - Business Wire
- 7 weeks ago - Alcon Agrees to Acquire LENSAR, Inc. - Business Wire